BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 2477690)

  • 1. Induced expression from the Moloney murine leukemia virus long terminal repeat during differentiation of human myeloid cells is mediated through its transcriptional enhancer.
    Reisman D; Rotter V
    Mol Cell Biol; 1989 Aug; 9(8):3571-5. PubMed ID: 2477690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Addition of substitution of simian virus 40 enhancer sequences into the Moloney murine leukemia virus (M-MuLV) long terminal repeat yields infectious M-MuLV with altered biological properties.
    Hanecak R; Pattengale PK; Fan H
    J Virol; 1988 Jul; 62(7):2427-36. PubMed ID: 2836623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Substitution of murine transthyretin (prealbumin) regulatory sequences into the Moloney murine leukemia virus long terminal repeat yields infectious virus with altered biological properties.
    Feuer G; Fan H
    J Virol; 1990 Dec; 64(12):6130-40. PubMed ID: 2173784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rearrangements and insertions in the Moloney murine leukemia virus long terminal repeat alter biological properties in vivo and in vitro.
    Fan H; Mittal S; Chute H; Chao E; Pattengale PK
    J Virol; 1986 Oct; 60(1):204-14. PubMed ID: 3747027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of glucocorticoid-responsive Moloney murine leukemia virus by insertion of regulatory sequences from murine mammary tumor virus into the long terminal repeat.
    Overhauser J; Fan H
    J Virol; 1985 Apr; 54(1):133-44. PubMed ID: 2983110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A single point mutation activates the Moloney murine leukemia virus long terminal repeat in embryonal stem cells.
    Grez M; Zörnig M; Nowock J; Ziegler M
    J Virol; 1991 Sep; 65(9):4691-8. PubMed ID: 1870196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retroviral-mediated gene expression in human myelomonocytic cells: a comparison of hematopoietic cell promoters to viral promoters.
    Malik P; Krall WJ; Yu XJ; Zhou C; Kohn DB
    Blood; 1995 Oct; 86(8):2993-3005. PubMed ID: 7579392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A transcriptional enhancer with specificity for erythroid cells is located in the long terminal repeat of the Friend murine leukemia virus.
    Bösze Z; Thiesen HJ; Charnay P
    EMBO J; 1986 Jul; 5(7):1615-23. PubMed ID: 3462001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inactivation of the Moloney murine leukemia virus long terminal repeat in murine fibroblast cell lines is associated with methylation and dependent on its chromosomal position.
    Hoeben RC; Migchielsen AA; van der Jagt RC; van Ormondt H; van der Eb AJ
    J Virol; 1991 Feb; 65(2):904-12. PubMed ID: 1702844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leukemogenicity of Moloney murine leukemia viruses carrying polyoma enhancer sequences in the long terminal repeat is dependent on the nature of the inserted polyoma sequences.
    Fan H; Chute H; Chao E; Pattengale PK
    Virology; 1988 Sep; 166(1):58-65. PubMed ID: 2842957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of collagenase IV gene expression and enzymatic activity by the Moloney murine leukemia virus long terminal repeat.
    Faller DV; Weng H; Choi SY
    Virology; 1997 Jan; 227(2):331-42. PubMed ID: 9018132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rat cellular mutants for expression of mRNA from the long terminal repeat of murine retrovirus.
    Isaka M; Inoue H; Tsukiyama T; Niwa O; Hakura A
    Virology; 1992 Jul; 189(1):141-9. PubMed ID: 1604805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue-specific gene expression from Mo-MLV retroviral vectors with hybrid LTRs containing the murine tyrosinase enhancer/promoter.
    Vile RG; Diaz RM; Miller N; Mitchell S; Tuszyanski A; Russell SJ
    Virology; 1995 Dec; 214(1):307-13. PubMed ID: 8525635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of the binding proteins and activity of the long terminal repeat of Moloney murine leukemia virus during differentiation of mouse embryonal carcinoma cells.
    Tsukiyama T; Niwa O; Yokoro K
    J Virol; 1991 Jun; 65(6):2979-86. PubMed ID: 2033663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Moloney murine leukemia virus long terminal repeat activates monocyte chemotactic protein-1 protein expression and chemotactic activity.
    Faller DV; Weng H; Graves DT; Choi SY
    J Cell Physiol; 1997 Aug; 172(2):240-52. PubMed ID: 9258345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Negative regulatory element associated with potentially functional promoter and enhancer elements in the long terminal repeats of endogenous murine leukemia virus-related proviral sequences.
    Ch'ang LY; Yang WK; Myer FE; Yang DM
    J Virol; 1989 Jun; 63(6):2746-57. PubMed ID: 2542587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Escape from in vivo restriction of Moloney mink cell focus-inducing viruses driven by the Mo+PyF101 long terminal repeat (LTR) by LTR alterations.
    Brightman BK; Farmer C; Fan H
    J Virol; 1993 Dec; 67(12):7140-8. PubMed ID: 8230436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of SV40-promoted gene expression by differentiation of preadipose cells.
    Djian P; Phillips M; Green H
    Genes Dev; 1988 Oct; 2(10):1251-7. PubMed ID: 2849579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel retroviral vectors for efficient expression of the multidrug resistance (mdr-1) gene in early hematopoietic cells.
    Baum C; Hegewisch-Becker S; Eckert HG; Stocking C; Ostertag W
    J Virol; 1995 Dec; 69(12):7541-7. PubMed ID: 7494260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mapping of DNase I-hypersensitive sites in the 5' and 3' long terminal repeats of integrated moloney murine leukemia virus proviral DNA.
    Thompson T; Fan H
    Mol Cell Biol; 1985 Apr; 5(4):601-9. PubMed ID: 2985961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.